Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
acquiror, adequacy, aimed, analytical, April, arbitration, attestation, attesting, backup, bearing, carried, certainty, chain, clearance, Code, companion, component, comprised, confidence, credit, cyotoxic, decision, deter, deterrent, diagnostic, digit, discontinued, domestic, double, driven, drop, encouraging, excipient, feasible, firm, FOLFIRINOX, forecast, forward, geographic, halted, hand, higher, IDMC, immaterial, impair, impairment, incorrect, increasingly, ingredient, input, interdependent, intrusion, investor, invite, jeopardize, logo, Metabolic, modification, move, overseen, oversight, pemetrexed, placebo, pretreated, properly, Qualitative, Quantitative, reliability, reproducibility, restate, sensitive, sought, stroma, supervision, supplemented, supplier, susceptible, taxable, turn, unblinded, understanding, underwritten, undue, unintended, uninterrupted, unqualified, viability, vulnerable, waiver
Removed:
accessible, accumulated, acting, activate, administered, AG, Alimta, alleged, AstraZeneca, astrocytoma, attainment, Avastin, Bayer, beginning, beneficially, blend, blood, broadening, bromo, Camptosar, carefully, chemotherapy, choose, cisplatin, coalition, coincide, communicated, comprehensive, contact, contrast, controller, convertible, crosslink, currency, cytotoxin, database, dated, debate, denominated, deposit, derivative, division, DNA, enacted, enhanced, essentially, examined, FDMA, finance, formed, frame, healthy, Hedging, high, hypoxic, inactive, inclusion, increasing, influence, insolvency, introduced, invest, invested, Investigator, isophosphoramide, journal, June, Kingdom, legislation, liquid, liquidity, location, Maine, maximizing, member, mustard, Nexavar, ninety, Onyx, ordered, ovarian, Overview, oxygenated, paclitaxel, partial, pazopanib, percent, Pfizer, PLC, portfolio, post, posting, potent, preservation, preserve, Proacta, processed, prostate, publicity, publish, purpose, radiotherapy, registrational, registry, resistance, resolution, Roche, Sanofi, scaling, segment, Serono, sponsored, Squibb, stromal, sufficiently, summarized, Taxotere, thirty, THLD, UK, website, Xeloda, York
Filing tables
Filing exhibits
Related press release
MTEM similar filings
Filing view
External links